A Schizophrenia-Related Deletion Leads to KCNQ2-Dependent Abnormal Dopaminergic Modulation of Prefrontal Cortical Interneuron Activity

Cerebral Cortex
Se Joon ChoiHui Zhang

Abstract

Altered prefrontal cortex function is implicated in schizophrenia (SCZ) pathophysiology and could arise from imbalance between excitation and inhibition (E/I) in local circuits. It remains unclear whether and how such imbalances relate to genetic etiologies. We used a mouse model of the SCZ-predisposing 22q11.2 deletion (Df(16)A+/- mice) to evaluate how this genetic lesion affects the excitability of layer V prefrontal pyramidal neurons and its modulation by dopamine (DA). Df(16)A+/- mice have normal balance between E/I at baseline but are unable to maintain it upon dopaminergic challenge. Specifically, in wild-type mice, D1 receptor (D1R) activation enhances excitability of layer V prefrontal pyramidal neurons and D2 receptor (D2R) activation reduces it. Whereas the excitatory effect upon D1R activation is enhanced in Df(16)A+/- mice, the inhibitory effect upon D2R activation is reduced. The latter is partly due to the inability of mutant mice to activate GABAergic parvalbumin (PV)+ interneurons through D2Rs. We further demonstrate that reduced KCNQ2 channel function in PV+ interneurons in Df(16)A+/- mice renders them less capable of inhibiting pyramidal neurons upon D2 modulation. Thus, DA modulation of PV+ interneurons and c...Continue Reading

References

Aug 17, 1995·Nature·G V Williams, P S Goldman-Rakic
Oct 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D R Weinberger, K F Berman
Mar 17, 2000·Brain Research. Brain Research Reviews·P S Goldman-RakicG V Williams
Mar 17, 2001·Nature Reviews. Neuroscience·T J Jentsch
Sep 22, 2001·Neuroscience and Biobehavioral Reviews·N M RichtandS M Strakowski
Oct 18, 2002·Neuron·Wolfram Schultz
Feb 13, 2003·The European Journal of Neuroscience·Patricio O'Donnell
Feb 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Wen-Jun Gao, Patricia S Goldman-Rakic
May 20, 2003·Nature Neuroscience·Naoto HoshiHaruhiro Higashida
Jun 27, 2003·Pflügers Archiv : European journal of physiology·Trine LjungstromSøren-Peter Olesen
Jan 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Clint E Young, Charles R Yang
Feb 7, 2004·Science·Min WangPatricia S Goldman-Rakic
Jun 4, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kuei Y Tseng, Patricio O'Donnell
Oct 29, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bidisha ChattopadhyayaZ Josh Huang
Nov 2, 2005·Nature Reviews. Neuroscience·Patrick Delmas, David A Brown
Apr 28, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bilal HaiderDavid A McCormick
May 31, 2006·The Pharmacogenomics Journal·M BorsottoI Chumakov
Nov 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·J Josh LawrenceChris J McBain
Feb 6, 2007·Nature Neuroscience·Susheel VijayraghavanAmy F T Arnsten
Oct 22, 2008·Annual Review of Pharmacology and Toxicology·Jean-Martin BeaulieuMarc G Caron
Nov 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kuei Y TsengPatricio O'Donnell
Nov 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yuanyuan JiBai Lu
Dec 2, 2009·Nature Reviews. Drug Discovery·Heike WulffLuis A Pardo
Dec 23, 2009·Schizophrenia Bulletin·P Alexander Arguello, Joseph A Gogos
May 21, 2010·Nature Reviews. Neuroscience·Maria KarayiorgouJoseph A Gogos
Jul 2, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David KapfhamerUlrike Heberlein
Jul 16, 2010·Journal of Neurochemistry·Mikko KäenmäkiPekka T Männistö
Sep 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Edwin Santini, James T Porter
Oct 6, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Liam J DrewMaria Karayiorgou
Dec 15, 2010·Developmental Neurobiology·Bernardo RudyJens Hjerling-Leffler
Dec 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nikolai C DembrowDaniel Johnston
Dec 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Aaron J GruberPatricio O'Donnell
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Karine FénelonJoseph A Gogos
Jul 29, 2011·Nature·Min WangAmy F T Arnsten
Sep 20, 2011·Nature Genetics·UNKNOWN Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium
Nov 1, 2011·Annual Review of Medicine·Laura Rodriguez-MurilloMaria Karayiorgou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.